Korea Arlico Pharm Co.,Ltd. 260660.KQ Stock
5030 KRW
{{ price }}
-0.592885%
{{change_pct}}%
COUNTRY
South Korea
Exchange
KOSDAQ
Market Cap
48.27B KRW
LOW - HIGH [24H]
5010
-
5040 KRW
VOLUME [24H]
5.65K KRW
{{ volume }}
P/E Ratio
0
Earnings per share
0 KRW
Korea Arlico Pharm Co.,Ltd. Price Chart
Korea Arlico Pharm Co.,Ltd. 260660.KQ Financial and Trading Overview
| Korea Arlico Pharm Co.,Ltd. stock price | 5030 KRW |
| Previous Close | 5960 KRW |
| Open | 5960 KRW |
| Bid | 5840 KRW x 0 |
| Ask | 5890 KRW x 0 |
| Day's Range | 5810 - 5960 KRW |
| 52 Week Range | 5060 - 7800 KRW |
| Volume | 24.91K KRW |
| Avg. Volume | 70.65K KRW |
| Market Cap | 56.42B KRW |
| Beta (5Y Monthly) | 1.084631 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 KRW |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
260660.KQ Valuation Measures
| Enterprise Value | 103.93B KRW |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.30649492 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 0.565 |
| Enterprise Value/EBITDA | 6.533 |
Trading Information
Korea Arlico Pharm Co.,Ltd. Stock Price History
| Beta (5Y Monthly) | 1.084631 |
| 52-Week Change | N/A |
| S&P500 52-Week Change | N/A |
| 52 Week High | 7800 KRW |
| 52 Week Low | 5060 KRW |
| 50-Day Moving Average | 6090.2 KRW |
| 200-Day Moving Average | 6364.75 KRW |
260660.KQ Share Statistics
| Avg. Volume (3 month) | 70.65K KRW |
| Avg. Daily Volume (10-Days) | 34.64K KRW |
| Shares Outstanding | 9.6M |
| Float | 9.5M |
| Short Ratio | N/A |
| % Held by Insiders | 40.65% |
| % Held by Institutions | 0.26% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | N/A |
| Trailing Annual Dividend Yield | N/A |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | June 30, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 5.40% |
| Operating Margin (ttm) | 6.65% |
| Gross Margin | 62.29% |
| EBITDA Margin | 8.64% |
Management Effectiveness
| Return on Assets (ttm) | 5.05% |
| Return on Equity (ttm) | 11.08% |
Income Statement
| Revenue (ttm) | 184.09B KRW |
| Revenue Per Share (ttm) | 12259.85 KRW |
| Quarterly Revenue Growth (yoy) | 30.59% |
| Gross Profit (ttm) | 106.87B KRW |
| EBITDA | 15.91B KRW |
| Net Income Avi to Common (ttm) | 9.94B KRW |
| Diluted EPS (ttm) | N/A |
| Quarterly Earnings Growth (yoy) | 91.90% |
Balance Sheet
| Total Cash (mrq) | 27.96B KRW |
| Total Cash Per Share (mrq) | 1863.32 KRW |
| Total Debt (mrq) | 36.77B KRW |
| Total Debt/Equity (mrq) | 39.16 KRW |
| Current Ratio (mrq) | 1.314 |
| Book Value Per Share (mrq) | N/A |
Cash Flow Statement
| Operating Cash Flow (ttm) | 6.96B KRW |
| Levered Free Cash Flow (ttm) | -23025991680 KRW |
Profile of Korea Arlico Pharm Co.,Ltd.
| Country | South Korea |
| State | N/A |
| City | Seoul |
| Address | 7-21, Baumoe-ro 27-gil |
| ZIP | N/A |
| Phone | 82 2 585 0004 |
| Website | https://www.arlico.co.kr |
| Industry | |
| Sector(s) | |
| Full Time Employees | N/A |
Korea Arlico Pharm Co.,Ltd. engages in the research and development, production, and sale of medicines in South Korea. The company provides ETC, OTC, health functional, and other products; and active ingredients. It offers products in the areas of circulatory system, anti-platelet, dementia, muscle relaxants, diabetes, nsaids and analgesics, antibiotic and chemotherapy, allergy and respiratory disease, ointment/cream, health functional food, vitamin and health supplements, anti-inflammatory analgesic, digestive system, and metabolic disease. The company is based in Seoul, South Korea.
Q&A For Korea Arlico Pharm Co.,Ltd. Stock
What is a current 260660.KQ stock price?
Korea Arlico Pharm Co.,Ltd. 260660.KQ stock price today per share is 5030 KRW.
How to purchase Korea Arlico Pharm Co.,Ltd. stock?
You can buy 260660.KQ shares on the KOSDAQ exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Korea Arlico Pharm Co.,Ltd.?
The stock symbol or ticker of Korea Arlico Pharm Co.,Ltd. is 260660.KQ.
How many shares does Korea Arlico Pharm Co.,Ltd. have in circulation?
The max supply of Korea Arlico Pharm Co.,Ltd. shares is 9.6M.
What is Korea Arlico Pharm Co.,Ltd. Price to Earnings Ratio (PE Ratio)?
Korea Arlico Pharm Co.,Ltd. PE Ratio is now.
What was Korea Arlico Pharm Co.,Ltd. earnings per share over the trailing 12 months (TTM)?
Korea Arlico Pharm Co.,Ltd. EPS is 0 KRW over the trailing 12 months.
Korea Arlico Pharm Co.,Ltd. 260660.KQ included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| Kosdaq Small Index KQSM | 2737.08 KRW 2.07 USD |
-1.29
|
354.59K KRW 268 USD | 2724.25 KRW 2.06 USD | 2751.73 KRW 2.08 USD | — - | 354.59K KRW 268 USD |
| Kosdaq Manufacturing Index KQ12 | 2779.56 KRW 2.1 USD |
-1.27
|
210.65K KRW 159 USD | 2753.96 KRW 2.08 USD | 2788.98 KRW 2.11 USD | — - | 210.65K KRW 159 USD |
| Kosdaq Pharmaceuticals Index KQ26 | 9230.64 KRW 6.97 USD |
-0.48
|
22.23K KRW 17 USD | 9102.9 KRW 6.87 USD | 9268.21 KRW 7 USD | — - | 22.23K KRW 17 USD |
- {{ link.label }} {{link}}